Cargando…

TLR-independent activation of NK cells during systemic inflammation

Detalles Bibliográficos
Autores principales:	Rasid, O, Cavaillon, J-M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273927/ http://dx.doi.org/10.1186/cc14004

Ejemplares similares

TLR8 agonist VTX-2337 enhances NKG2D-mediated cytotoxicity of NK cells
por: Lu, Hailing, et al.
Publicado: (2013)

TLR-9, but not TLR-2, TLR-3 and TLR-4, is upregulated on peripheral blood mononuclear cells of patients with active systemic lupus erythematosus
por: Papadimitraki, ED, et al.
Publicado: (2005)

Unc93 homolog B1 restricts systemic lethal inflammation by orchestrating TLR7 and TLR9 response
por: Fukui, Ryutaro, et al.
Publicado: (2012)

Ninjurin 1 contributes to TLR-induced inflammation in endothelial cells
por: Jennewein, C, et al.
Publicado: (2012)

TLR-3 and TLR-7/8 ligands indirectly activate Langerhans cells when intradermally injected by triggering the recruitment of inflammatory cells
por: Epaulard, O, et al.
Publicado: (2012)

Promoting NK cell trafficking to improve therapeutic effect of NK cell therapy on osteosarcoma
por: Yang, Yuanzheng, et al.
Publicado: (2015)

CD24-mediated neutrophil death in inflammation: ex vivo study suggesting a potential role in sepsis
por: Parlato, M, et al.
Publicado: (2012)

IL-1 receptor antagonist restores IL-18 NK cell axis in systemic JIA
por: Vastert, Sebastiaan J, et al.
Publicado: (2012)

Cyclic dinucleotides (CDNs) anti-tumors response by activating DC and NK cell crosstalk
por: Fu, Juan, et al.
Publicado: (2014)

The effect of systemic iNOS inhibition during human endotoxemia on the development of TLR-tolerance in vitro
por: Pickkers, P, et al.
Publicado: (2006)

Immunomodulation and infection: identification of small molecule TLR3 blockers to combat deleterious inflammation in pneumonia
por: Sônego, F, et al.
Publicado: (2014)

P33. NK-92 cellular immunotherapy as an alternative to donor derived peripheral blood NK cells
por: Klingemann, H
Publicado: (2014)

Expression of Toll-like receptor (TLR) 2, TLR3, TLR4 and TLR7 is increased in rheumatoid arthritis synovium and regulates cytokine production by dendritic cells upon stimulation of TLR specific pathways
por: Roelofs, MF, et al.
Publicado: (2005)

NK cell HMGB1 mediates IL-2-induced “systemic autophagic” toxicity
por: Li, Guanqiao, et al.
Publicado: (2013)

Induction of systemic anti-melanoma immunity through intratumoral TLR-7/8 activation
por: Singh, Manisha, et al.
Publicado: (2014)

Systemic delivery of TLR9-activating/STAT3-blocking oligonucleotides induces leukemia regression
por: Zhang, Qifang, et al.
Publicado: (2014)

P10-11. NK cells do not accumulate at sites of HIV-replication but show increased activation
por: Luteijn, R, et al.
Publicado: (2009)

PD-1 is a marker of activation on tumor infiltrating NK cells in head and neck cancer
por: Concha-Benavente, Fernando, et al.
Publicado: (2015)

The endogenous TLR-4 ligands MRP8/14 as biomarkers of inflammation in Familial Mediterranean Fever (FMF)
por: Wittkowski, H, et al.
Publicado: (2008)

IL-2 analogues: novel agents circumventing the expansion of T regulatory cells while promoting NK cell activation during IL-2 therapy
por: Sim, Geok Choo, et al.
Publicado: (2013)

KIR-HLA footprints and NK cell-mediated recognition of HIV-1
por: Thobakgale, CF, et al.
Publicado: (2012)

Impaired NK and NKT cells immunobiology in rheumatoid arthritis
por: Aggarwal, Ashish, et al.
Publicado: (2012)

Microcirculatory hyporesponsiveness in lipopolysaccharide-induced inflammation is endothelial cell dependent but calcium independent
por: Ouellette, Y
Publicado: (2006)

Human mast cells respond to viral infection by recruiting NK cells and T cells
por: Burke, SM, et al.
Publicado: (2010)

Homeostatic pulmonary microenvironment is responsible for alveolar macrophages resistance to endotoxin tolerance
por: Philippart, F, et al.
Publicado: (2012)

P67. Targeted natural killer (NK) cell based adoptive immunotherapy for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy (RCT) – clinical application of NK cells activated by heat shock protein 70 (Hsp70)
por: Specht, HM, et al.
Publicado: (2014)

Inhibition of natural killer (nk) cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome
por: Cifaldi, Loredana, et al.
Publicado: (2014)

P24. Aviscumine enhances NK- cytotoxicity against tumor cells
por: Gamerith, G, et al.
Publicado: (2014)

Palmitoleate attenuates diet induced insulin resistance and hepatic inflammation independently of PPAR-α
por: Souza, Camila O, et al.
Publicado: (2014)

Natural killer cell status and tolerance in mouse and human bacterial sepsis
por: Souza-Fonseca-Guimaraes, F, et al.
Publicado: (2012)

TLR7/9 antagonist reduces HIV-1-induced immune activation
por: Chang, J, et al.
Publicado: (2012)

P16. Differential susceptibility of human and mouse NK cells to malignant cell-induced abnormalities in autologous combinations: a potential mechanism for the NK cell-based immunotherapy efficacy
por: Sconocchia, G, et al.
Publicado: (2014)

Genomic scale analysis of NK cells impact on response to IFN-α
por: Ascierto, Maria L, et al.
Publicado: (2013)

Serum cholinesterase activity as an early indicator of systemic inflammation
por: Zivkovic, AR, et al.
Publicado: (2015)

Frequent and strong antibody-mediated NK cell activation to HIV-1 Env in individuals with chronic HIV-1 infection
por: Thobakgale, C, et al.
Publicado: (2012)

Natural Killer (NK) cell responses at female genital mucosa to SIV vaginal challenge
por: Shang, L, et al.
Publicado: (2012)

Innate immunity and inflammation in sepsis: mechanisms by which acute ethanol exposure alters the course of sepsis and the effect to TLR4 signaling
por: Jan, B, et al.
Publicado: (2010)

Expression and function of FcγRII on NK cells in rhesus macaques
por: He, X, et al.
Publicado: (2012)

Periodic fevers associated with celiac disease and marked increase of NK cells
por: Sediva, A
Publicado: (2015)

Siglec-7/-9 ligands shield tumor cells from NK cell attack
por: Jandus, Camilla, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4b4ehgnp4dbvgct23qkm11oi4g